News | Artificial Intelligence | July 14, 2021

The software provides fully automated precise segmentation and robust assessment of chondral lesions (location, diameter, shape, boundaries), resulting in improved diagnosis and treatment selection, supporting faster recovery

 

 

The software provides fully automated precise segmentation and robust assessment of chondral lesions (location, diameter, shape, boundaries), resulting in improved diagnosis and treatment selection, supporting faster recovery

July 14, 2021 — RSIP Vision, a clinically proven leader in real-world AI solutions for medical image analysis, announced a new articular cartilage segmentation tool for accurate, non-invasive assessment of chondral lesions in MRI scans. This new software module enables quick and accurate deep learning-based segmentation of joint cartilage from MRI scans of hips, knees, and ankles. RSIP Vision’s advanced algorithms provide accurate measurement of the location and geometry of osteochondral lesions in MRI images that enable the physician to easily evaluate the extent of the damage, select the appropriate treatment and assess its efficacy. 

Chondral lesions are particularly prevalent among young and active patients including athletes. Due to the avascular nature of articular cartilage, the healing potential is limited. These lesions hinder the indispensable role that cartilage plays in creating a smooth, low-friction surface for transmission of forces across the joint. In many cases, Chondral lesions limit the athlete’s ability to participate in sports and even affect their daily activities. Cartilage segmentation is a crucial tool that aids the physician in choosing the optimal treatment for the patient. To help the physician assess the most suitable procedure from a variety of cartilage-sparing procedures (mosaicplasty, microfracture, osteochondral autograft transfer system, autologous chondrocyte implantation), the articular cartilage is imaged using MRI, segmented and then evaluated for lesion size (diameter), shape and boundaries. Any viable cartilage in non-weight bearing areas is also mapped for possible cartilage transfer (such as mosaicplasty or OATS).  

RSIP Vision has extensive experience and expertise in MRI segmentation of soft tissues, offering fully automated segmentations with a submillimeter accuracy. The new module from RSIP Vision utilizes state-of-the-art deep learning (DL) algorithms designed to deal with MRI scans of cartilage in hip, knee, and ankle joints. The new technology is vendor-neutral and will be available to third-party MRI manufacturers and medical device vendors, allowing the physicians using the system, an improved way to evaluate cartilage damage, select the optimal treatment option and follow-up postoperatively.

RSIP Vision’s new module is essential in sports medicine, where cartilage damage is a common and debilitating problem among athletes from all fields. Using RSIP Vision’s module, physicians can provide athletes with better evaluation of their cartilage integrity and provide the best fitting cartilage-sparing treatment, resulting in improved outcome and shortened recuperation downtimes.  

“It is very valuable to be able to accurately map chondral lesions preoperatively,” said Shai Factor, M.D., an orthopedic surgeon at Tel Aviv Sourasky Medical Center in Israel. “Analyzing the parameters of the lesion and its boundaries allows the surgeon, along with the patient, to choose the ideal cartilage repair technique. Additionally, in cases where cartilage transfer is the chosen option, this technology will make it possible to map the donor cartilage area as well and plan the surgery in the best way that will lead to better outcomes.”

For more information: www.rsipvision.com


Related Content

News | Computed Tomography (CT)

March 31, 2023 — Philips, a global leader in health technology, and Connally Memorial Medical Center (CMMC), today ...

Time March 31, 2023
arrow
News | Enterprise Imaging

March 30, 2023 — Hyland Healthcare, whose solutions are used by more than half of the hospitals in the United States ...

Time March 30, 2023
arrow
News | Clinical Trials

March 30, 2023 —According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...

Time March 30, 2023
arrow
News | Magnetic Resonance Imaging (MRI)

March 30, 2023 — GenesisCare, one of the leading integrated cancer care providers in the United States, Australia, Spain ...

Time March 30, 2023
arrow
News | HIMSS

March 29, 2023 — Over 2,000 leading executives have committed to attend HIMSS Global Health Conference & Exhibition, now ...

Time March 29, 2023
arrow
News | Artificial Intelligence

March 29, 2023 — In a partnership which aims to provide faster and safer medical imaging across Australia and New ...

Time March 29, 2023
arrow
News | Radiology Business

March 27, 2023 — Swissray brand has a long history of pioneering digital x-ray technology. One of the first markets that ...

Time March 27, 2023
arrow
News | Information Technology

March 27, 2023 — Royal Philips, a global leader in health technology, today announced the debut of Philips Virtual Care ...

Time March 27, 2023
arrow
News | Artificial Intelligence

March 27, 2023 — DeepTek.ai, a leading radiology AI company offering multiple AI-powered solutions for radiology ...

Time March 27, 2023
arrow
News | Breast Imaging

March 23, 2023 — Lumicell, Inc., a privately held company focused on innovative fluorescence-guided imaging technologies ...

Time March 24, 2023
arrow
Subscribe Now